Ajanta Pharma has submitted a copy of notice published in the newspapers, on November 22, 2016 as required under IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 (Rules), inviting attention of concerned shareholders to lodge their claims in respect of unclaimed dividends of the Company for last seven years, failing which their shares would be transferred to lnvestor Education and Protection Fund (IEPF) Suspense account, in accordance with section 124(6) of the Companies Act, 2013 read with Rules.
The above information is a part of company’s filings submitted to BSE.
